COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

por Niemann, Carsten U., Awan, Farrukh T., Fogliatto, Laura, Nikitin, Eugene, Samoilova, Olga, Habib, Adel, Foroutanpour, Kayhan, Kuptsova-Clarkson, Nataliya, Opat, Stephen
Publicado 2022